ArticleFrontiers in immunology2021

Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors.

Tinglei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.